Scarica l'app Stockscreener
9.98
0.10%
-0.010
Dopo l'orario di chiusura:
9.98
Apogee Acquisition Corp Borsa (AACP) Ultime notizie
Apogee Therapeutics (NASDAQ: APGE) backs AbbVie’s $135.11‑per‑share all‑cash deal - Stock Titan
Price to book forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Apogee Acquisition (AACP) Stock Trends and Sentiment 2026 - MarketBeat
Enterprise value to revenue forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Apogee Acquisition Corp Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Apogee Acquisition Corp Rings the Closing Bell - Nasdaq
Price to sales forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Iron Dome Acquisition Corporation Rings the Nasdaq Stock Market Opening Bell - Nasdaq
AACPU Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Price to sales forward of Apogee Acquisition Corp – BOATS:AACPR - TradingView
AACPR Stock Price, News & Analysis - Stock Titan
APOGEE ACQUISITION (AACPW) Stock Price, News & Analysis - Stock Titan
Price to sales forward of Apogee Acquisition Corp – NASDAQ:AACPR - TradingView
AbbVie acquires Apogee Therapeutics for $10.9 billion - qz.com
Apogee Therapeutics (APGE) Proxy filing Summary - Quartr
AbbVie to buy Apogee Therapeutics (APGE) for $135.11 per share — significant premium - Stock Titan
Enterprise value to EBITDA forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Apogee Enterprises Completes $115 Million Acquisition of Kalwall Companies to Expand Architectural Solutions - Minichart
H.C. Wainwright Keeps Buy Rating on Oruka (ORKA) After Apogee Acquisition News - Insider Monkey
Apogee completes strategic acquisition of Keller Companies - TipRanks
Apogee Enterprises completes Kalwall acquisition for $115 million - Investing.com
Apogee Enterprises completes acquisition of Kalwall Companies - scanx.trade
Apogee Enterprises, Inc. acquired Kalwall Corporation from the Keller family. - marketscreener.com
Ares Acquisition Corporation III Announces Pricing of Upsized $345 Million Initial Public Offering - Yahoo Finance
Enterprise value to EBIT forward of Apogee Acquisition Corp – NASDAQ:AACPW - TradingView
AbbVie Announces $10.9 Billion Acquisition of Apogee Therapeutics - HarianBasis.co
Enterprise value to revenue forward of Apogee Acquisition Corp – BOATS:AACPU - TradingView
Price to sales forward of Apogee Acquisition Corp – BOATS:AACPU - TradingView
Enterprise value to revenue forward of Apogee Acquisition Corp – NASDAQ:AACPW - TradingView
Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9 Bill - Benzinga
AACPR|Apogee Acquisition Rights|| - TradingKey
Price to book forward of Apogee Acquisition Corp – NASDAQ:AACPU - TradingView
Price to sales forward of Apogee Acquisition Corp – NASDAQ:AACPU - TradingView
Mizuho downgrades Apogee Therapeutics stock on AbbVie acquisition - Investing.com
Mizuho downgrades Apogee Therapeutics stock on AbbVie acquisition By Investing.com - Investing.com Canada
After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching - Yahoo Finance
AbbVie Acquires Apogee Therapeutics for 10.9 Billion Dollars - HarianBasis.co
Cash buyout for Apogee (NASDAQ: APGE) at $135.11 a share - Stock Titan
AACP|Apogee Acquisition Ord Shs Class A|Price:9.960|Chg%:0.00 - TradingKey
Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee Acquisition - Insider Monkey
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio - Investing News Network
Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B Merger - Yahoo Finance
AbbVie: Apogee Acquisition Brings Significant Weight to Immunology Pipeline - Morningstar
AbbVie sharpens immunology focus with $10.9 billion Apogee deal - 102.7 WBOW
AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition (NASDAQ:APGE) - Seeking Alpha
AbbVie to Acquire Apogee Therapeutics for $10.9B - Genetic Engineering and Biotechnology News
AbbVie Acquires Apogee Therapeutics in 10.9 Billion Dollar Deal - HarianBasis.co
Apogee Enterprises Acquires Kalwall Companies for 115 Million Dollars - HarianBasis.co
AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs - BioPharma Dive
Apogee Enterprises (APOG) Makes a $115 Million Bet; Could This Acquisition Reshape Its Growth Story? - Insider Monkey
AbbVie Buys Apogee for $10.9 Billion to Acquire Inflammatory Disease Drug Pipeline - streamlinefeed.co.ke
AbbVie Bets Big on Respiratory Pipeline With Apogee Acquisition -- Company Talk - Moomoo
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Immunology Deal - citybiz
AbbVie to acquire Apogee Therapeutics (NASDAQ: APGE) in $10.9B cash deal - Stock Titan
AbbVie (NYSE: ABBV) to acquire Apogee Therapeutics in $10.9B immunology deal - Stock Titan
AbbVie (ABBV) Stock Dips as $10.9B Apogee Therapeutics Acquisition Nears Completion - MEXC
0.08%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):